<?xml version="1.0" encoding="UTF-8"?>
<p id="P6">Dementia affects 9% of the population (
 <xref rid="R68" ref-type="bibr">Langa et al., 2017</xref>; 
 <xref rid="R81" ref-type="bibr">McKhann et al., 2011</xref>) and exacts a large societal and financial burden (
 <xref rid="R3" ref-type="bibr">Alzheimer’s Association, 2019</xref>). The most common dementia is Alzheimer’s disease (AD), characterized pathologically by neurofibrillary tangles, consisting of filamentous hyperphosphorylated microtubule-associated protein tau (
 <italic>MAPT</italic>; tau), inclusions, and senile plaques, consisting of Aβ deposits (
 <xref rid="R24" ref-type="bibr">De Strooper and Karran, 2016</xref>; 
 <xref rid="R40" ref-type="bibr">Goate et al., 1991</xref>; 
 <xref rid="R66" ref-type="bibr">Lage et al., 2007</xref>; 
 <xref rid="R106" ref-type="bibr">Schneider et al., 2009</xref>; 
 <xref rid="R117" ref-type="bibr">Vinters, 2015</xref>). Several neurodegenerative conditions are related to AD due to shared alterations in proteostasis and pathological protein aggregates in brain including progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), and Parkinson’s disease (PD) (
 <xref rid="R5" ref-type="bibr">Arendt et al., 2016</xref>; 
 <xref rid="R19" ref-type="bibr">Cummings, 2003</xref>; 
 <xref rid="R29" ref-type="bibr">Erkkinen et al., 2018</xref>; 
 <xref rid="R65" ref-type="bibr">Kovacs, 2015</xref>). Although common and rare genetic variants in 
 <italic>MAPT</italic> cause or increase the risk for AD, PSP (
 <xref rid="R16" ref-type="bibr">Coppola et al., 2012</xref>; 
 <xref rid="R25" ref-type="bibr">Desikan et al., 2015</xref>), FTD, and PD, the risk for these disorders is heterogeneous and complex (
 <xref rid="R13" ref-type="bibr">Chang et al., 2017</xref>; 
 <xref rid="R14" ref-type="bibr">Chen et al., 2018</xref>; 
 <xref rid="R31" ref-type="bibr">Ferrari et al., 2014</xref>; 
 <xref rid="R61" ref-type="bibr">Karch and Goate, 2015</xref>; 
 <xref rid="R107" ref-type="bibr">Seelaar et al., 2011</xref>). So, despite advances in identifying genetic contributions to dementia disease risk, understanding how risk factors may converge on specific molecular pathways remains a critical gap in our knowledge (
 <xref rid="R9" ref-type="bibr">Bonham et al., 2018</xref>; 
 <xref rid="R92" ref-type="bibr">Parikshak et al., 2015</xref>).
</p>
